A previous study showed that polypeptide-specific antigen (TPS), a serological marker of K18 that is widely used as a marker for various cancers, is a better marker for differentiating NASH from simple fatty liver [137]. The gene discussed is KRT18; the disease is metabolic dysfunction-associated steatohepatitis.